Form 8-K - Current report:
SEC Accession No. 0001628280-23-042550
Filing Date
2023-12-22
Accepted
2023-12-22 08:03:14
Documents
14
Period of Report
2023-12-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcnnf-20231222.htm   iXBRL 8-K 37272
2 EX-99.1 pressreleasegetmancfo-2023.htm EX-99.1 7648
6 GRAPHIC img6234483_0a.jpg GRAPHIC 27894
  Complete submission text file 0001628280-23-042550.txt   203214

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcnnf-20231222.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcnnf-20231222_lab.xml EX-101.LAB 21370
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcnnf-20231222_pre.xml EX-101.PRE 11036
8 EXTRACTED XBRL INSTANCE DOCUMENT tcnnf-20231222_htm.xml XML 2433
Mailing Address 6749 BEN BOSTIC ROAD QUINCY FL 32351
Business Address 6749 BEN BOSTIC ROAD QUINCY FL 32351 8502988866
Trulieve Cannabis Corp. (Filer) CIK: 0001754195 (see all company filings)

EIN.: 581882476 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56248 | Film No.: 231507192
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)